Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27153 | ||
MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27157 | ||
MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27161 | ||
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188042 |
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188045 |
MINT-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-01-04 | 2018-02-23 | 34914 |
MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71066 |
MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113190 |
MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-07 | 2018-01-04 | 28570 |
MINT-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217684 |
MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169555 |
MINT-LEVOCARB | 10MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32263 |
MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
MINT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100582 |
MINT-PAROXETINE | 10MG | TABLET | Resolved | 2018-01-09 | 2018-04-12 | 35476 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |
MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |